TIGIT and lung carcinoma: For instance, TIGIT and TIM-3 inhibition in mice cooperated to promote an antitumor immune response (135); dual blockade of TIGIT and LAG3 improved the treatment efficacy in a mouse model of anti-PD-1-resistant lung cancer (138).